BR9702101A - Hibridoma e anticorpo monoclonal - Google Patents

Hibridoma e anticorpo monoclonal

Info

Publication number
BR9702101A
BR9702101A BR9702101A BR9702101A BR9702101A BR 9702101 A BR9702101 A BR 9702101A BR 9702101 A BR9702101 A BR 9702101A BR 9702101 A BR9702101 A BR 9702101A BR 9702101 A BR9702101 A BR 9702101A
Authority
BR
Brazil
Prior art keywords
hybridoma
monoclonal antibody
antibodies
immunospecific
hybridomas
Prior art date
Application number
BR9702101A
Other languages
English (en)
Inventor
Michael W Gallatin
Monica Van Der Vieren
Original Assignee
Icos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icos Corp filed Critical Icos Corp
Publication of BR9702101A publication Critical patent/BR9702101A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6816—Hybridisation assays characterised by the detection means
    • C12Q1/6818—Hybridisation assays characterised by the detection means involving interaction of two or more labels, e.g. resonant energy transfer
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
BR9702101A 1996-02-22 1997-02-24 Hibridoma e anticorpo monoclonal BR9702101A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/605,672 US5817515A (en) 1993-12-23 1996-02-22 Human B2 integrin alpha subunit antibodies
PCT/US1997/002713 WO1997031099A1 (en) 1996-02-22 1997-02-24 Human beta 2 integrin alpha subunit

Publications (1)

Publication Number Publication Date
BR9702101A true BR9702101A (pt) 1999-07-20

Family

ID=24424704

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9702101A BR9702101A (pt) 1996-02-22 1997-02-24 Hibridoma e anticorpo monoclonal

Country Status (18)

Country Link
US (1) US5817515A (pt)
EP (1) EP0835301B1 (pt)
JP (1) JP2001526524A (pt)
CN (1) CN1103812C (pt)
AT (1) ATE293685T1 (pt)
AU (1) AU723110B2 (pt)
BR (1) BR9702101A (pt)
CA (1) CA2218755C (pt)
CZ (1) CZ287921B6 (pt)
DE (1) DE69733051D1 (pt)
FI (1) FI974018A (pt)
HU (1) HU223977B1 (pt)
IL (1) IL122011A (pt)
NO (1) NO318764B1 (pt)
PL (1) PL187013B1 (pt)
RU (1) RU2183671C2 (pt)
SK (1) SK283135B6 (pt)
WO (1) WO1997031099A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620915B2 (en) * 1993-12-23 2003-09-16 Icos Corporation Monoclonal antibodies specific for integrin α-d subunit
US5837478A (en) * 1993-12-23 1998-11-17 Icos Corporation Method of identifying modulators of binding between and VCAM-1
US20030055231A1 (en) * 1998-10-28 2003-03-20 Jian Ni 12 human secreted proteins
EP1267926A2 (en) 2000-03-17 2003-01-02 Millennium Pharmaceuticals, Inc. Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
WO2023235971A1 (en) * 2022-06-08 2023-12-14 The Regents Of The University Of California Antibodies and immunotherapies that target the active conformation of integrin beta 2

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4271139A (en) * 1978-03-27 1981-06-02 Hiram Hart Scintillation proximity assay
US4568649A (en) * 1983-02-22 1986-02-04 Immunex Corporation Immediate ligand detection assay
WO1992006697A1 (en) * 1990-10-23 1992-04-30 Repligen Corporation Anti-inflammatory composition
CA2120500A1 (en) * 1991-10-01 1993-04-15 Mitsuaki Isobe Preventing allograft rejection with antibodies to adhesion molecules
EP0610290B1 (en) * 1991-10-04 1999-05-26 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Manufacture of a medicament for treatment of ocular inflammation by blockage of cell adhesion molecules
US5470953A (en) * 1993-12-23 1995-11-28 Icos Corporation Human β2 integrin α subunit
WO1995027736A1 (en) * 1994-04-12 1995-10-19 Boehringer Ingelheim Pharmaceuticals, Inc. Use of agents which block intercellular adhesion molecule/receptor interaction in the treatment of respiratory viral infection

Also Published As

Publication number Publication date
HUP9901579A3 (en) 2001-10-29
CN1189851A (zh) 1998-08-05
US5817515A (en) 1998-10-06
SK140997A3 (en) 1998-09-09
CZ328697A3 (cs) 1998-07-15
EP0835301A1 (en) 1998-04-15
WO1997031099A1 (en) 1997-08-28
PL187013B1 (pl) 2004-04-30
NO318764B1 (no) 2005-05-02
FI974018A (fi) 1997-12-03
EP0835301B1 (en) 2005-04-20
PL323195A1 (en) 1998-03-16
AU2133397A (en) 1997-09-10
CA2218755C (en) 1999-08-31
CA2218755A1 (en) 1997-08-28
SK283135B6 (sk) 2003-03-04
HUP9901579A2 (hu) 1999-08-30
RU2183671C2 (ru) 2002-06-20
HU223977B1 (hu) 2005-03-29
CZ287921B6 (cs) 2001-03-14
NO974852D0 (no) 1997-10-21
AU723110B2 (en) 2000-08-17
IL122011A0 (en) 1998-03-10
JP2001526524A (ja) 2001-12-18
IL122011A (en) 2001-05-20
NO974852L (no) 1997-12-19
FI974018A0 (fi) 1997-10-21
CN1103812C (zh) 2003-03-26
ATE293685T1 (de) 2005-05-15
DE69733051D1 (de) 2005-05-25

Similar Documents

Publication Publication Date Title
ATE208820T1 (de) Humanisierte antikoerper
ES2187954T3 (es) Anticuerpos anti-integrina avb3 antagonistas.
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
IS8950A (is) Einklóna mótefni gegn CTLA-4 úr manni.
KR950700413A (ko) 인간 인터루킨-5에 대한 인간화 모노클로날 항체의 고안, 클로닝 및 발현(Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5)
PT941121E (pt) Preparados farmaceuticos liofilizados, estaveis, de anticorpos monoclonais ou policlonais
IL154326A0 (en) Anti-dual integrin antibodies, compositions, methods and uses
DE69128273D1 (de) Für toxin b von clostridium difficile spezifische monoklonale antikörper
NO986050L (no) Renset overflateantigen, monoklonalt antistoff fra spermier og anvendelse derav
ITRM920457A0 (it) Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteinaumana.
EP0578515A3 (en) Humanized monoclonal antibodies.
EP0341684A3 (en) Human monoclonal antibody, hybridoma producing the same and pharmaceutical
BR9702101A (pt) Hibridoma e anticorpo monoclonal
TR199501542A2 (tr) Bagisiklik önleyici aktiviteye sahip monoklonal antikor parcalari.
EP0759943A4 (en) MONOCLONAL ANTIBODIES SPECIFIC TO AN ENDOGLYX-1 ANTIGEN OF VASCULAR ENDOTHELIAL CELLS, THE ANTIGEN ITSELF AND USES THEREOF
IL94912A0 (en) Monoclonal antibodies involved in alzheimer's disease,hybridomas secreting these monoclonal antibodies,antigen recognized by these antibodies,and their application
DE59608073D1 (de) Antikörper gegen ein, einen histidin-anteil aufweisendes fusionspolypeptid
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
DE69129582D1 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
BR1100555B1 (pt) anticorpos monoclonais humanizados.
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
HUP0003029A2 (hu) Ankrod specifikus monoklonális antitestek, antitestfragmentumok, keverékeik és alkalmazásuk
ZA986064B (en) Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use.
IT1284626B1 (it) Metodo per l'identificazione del virus b della vite (gvb), anticorpi monoclonali (mab) contro gvb e linea cellulare di ibridoma atta a
IE901956L (en) Monoclonal antibody.

Legal Events

Date Code Title Description
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 13A, 14A E 15A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 13A, 14A E 15A ANUIDADES.